Logo image of SDGR

SCHRODINGER INC (SDGR) Stock Fundamental Analysis

NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD

25.29  +0.41 (+1.65%)

After market: 24.5856 -0.7 (-2.79%)

Fundamental Rating

3

Taking everything into account, SDGR scores 3 out of 10 in our fundamental rating. SDGR was compared to 37 industry peers in the Health Care Technology industry. SDGR has a great financial health rating, but its profitability evaluates not so good. SDGR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SDGR had negative earnings in the past year.
SDGR had a negative operating cash flow in the past year.
SDGR had negative earnings in 4 of the past 5 years.
SDGR had negative operating cash flow in 4 of the past 5 years.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

SDGR has a Return On Assets (-22.73%) which is in line with its industry peers.
SDGR has a Return On Equity (-44.40%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -22.73%
ROE -44.4%
ROIC N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 63.64%, SDGR is in line with its industry, outperforming 56.76% of the companies in the same industry.
In the last couple of years the Gross Margin of SDGR has grown nicely.
SDGR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SDGR has been increased compared to 1 year ago.
The number of shares outstanding for SDGR has been increased compared to 5 years ago.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 1.88 indicates that SDGR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.88, SDGR is doing good in the industry, outperforming 62.16% of the companies in the same industry.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.88
ROIC/WACCN/A
WACC10.66%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.31 indicates that SDGR has no problem at all paying its short term obligations.
SDGR has a Current ratio of 3.31. This is in the better half of the industry: SDGR outperforms 78.38% of its industry peers.
A Quick Ratio of 3.31 indicates that SDGR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.31, SDGR is in the better half of the industry, outperforming 78.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.31
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for SDGR have decreased strongly by -575.93% in the last year.
The Revenue has decreased by -4.21% in the past year.
SDGR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.41% yearly.
EPS 1Y (TTM)-575.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.15%
Revenue 1Y (TTM)-4.21%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%19.14%

3.2 Future

Based on estimates for the next years, SDGR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.77% on average per year.
SDGR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.93% yearly.
EPS Next Y-1.25%
EPS Next 2Y6.31%
EPS Next 3Y14.77%
EPS Next 5YN/A
Revenue Next Year24.87%
Revenue Next 2Y21.69%
Revenue Next 3Y21.73%
Revenue Next 5Y20.93%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SDGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SDGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

SDGR's earnings are expected to grow with 14.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.31%
EPS Next 3Y14.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SDGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHRODINGER INC

NASDAQ:SDGR (5/2/2025, 8:22:43 PM)

After market: 24.5856 -0.7 (-2.79%)

25.29

+0.41 (+1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners98.88%
Inst Owner Change0.2%
Ins Owners2.42%
Ins Owner Change1.57%
Market Cap1.85B
Analysts81.25
Price Target32.41 (28.15%)
Short Float %17.05%
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.06%
Min EPS beat(2)-28.59%
Max EPS beat(2)14.46%
EPS beat(4)3
Avg EPS beat(4)0.31%
Min EPS beat(4)-28.59%
Max EPS beat(4)14.87%
EPS beat(8)5
Avg EPS beat(8)14.9%
EPS beat(12)8
Avg EPS beat(12)13.81%
EPS beat(16)9
Avg EPS beat(16)12.54%
Revenue beat(2)1
Avg Revenue beat(2)-5.32%
Min Revenue beat(2)-14.72%
Max Revenue beat(2)4.07%
Revenue beat(4)2
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-14.72%
Max Revenue beat(4)17.94%
Revenue beat(8)3
Avg Revenue beat(8)-2.01%
Revenue beat(12)7
Avg Revenue beat(12)5.27%
Revenue beat(16)9
Avg Revenue beat(16)5.28%
PT rev (1m)-0.98%
PT rev (3m)-0.69%
EPS NQ rev (1m)-1.65%
EPS NQ rev (3m)6.06%
EPS NY rev (1m)-0.6%
EPS NY rev (3m)-4.06%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)13.54%
Revenue NY rev (1m)-3.55%
Revenue NY rev (3m)-1.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.9
P/FCF N/A
P/OCF N/A
P/B 4.38
P/tB 4.43
EV/EBITDA N/A
EPS(TTM)-2.57
EYN/A
EPS(NY)-2.6
Fwd EYN/A
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-2.15
OCFYN/A
SpS2.84
BVpS5.77
TBVpS5.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.73%
ROE -44.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.64%
FCFM N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score2
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.7%
Cap/Sales 3.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 3.31
Altman-Z 1.88
F-Score2
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-575.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.15%
EPS Next Y-1.25%
EPS Next 2Y6.31%
EPS Next 3Y14.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.21%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%19.14%
Revenue Next Year24.87%
Revenue Next 2Y21.69%
Revenue Next 3Y21.73%
Revenue Next 5Y20.93%
EBIT growth 1Y-17.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.74%
EBIT Next 3Y22.94%
EBIT Next 5YN/A
FCF growth 1Y-9.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.09%
OCF growth 3YN/A
OCF growth 5YN/A